crohn's Disease and iBS

---

 https://academic.oup.com/pcm/article/7/1/pbae001/7577619?login=true

“HBOT serves as a reliable adjunctive approach for IBD. This assertion has been substantiated by numerous clinical studies.”

https://www.cell.com/heliyon/fulltext/S2405-8440(22)02295-2

“n this systematic review of 27 clinical studies and two observational studies, we found that HBOT could be combined with usual care to improve IBD outcomes without severe side effects and reduce the recurrence rates of UC. “

https://academic.oup.com/ibdjournal/article/28/4/611/6277724

“On meta-analysis, the overall rate of clinical response was 86%....and the rate of clinical remission was 67% “